India, Oct. 20 -- On Tuesday, Axcelis Technologies (ACLS) announced that it will begin construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, South K... Read More
India, Oct. 20 -- Haemonetics Corp. (HAE), a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval of the PerQseal Elite vascular closure system for large-bore art... Read More
India, Oct. 20 -- National Australia Bank Limited (NAUBF,NABZY,NAB.AX) said on Tuesday that it plans to reduce its internal workforce by up to 2,500 roles, or around 6%, in fiscal 2027. This move will... Read More
India, Oct. 20 -- Germany's industrial producer prices rose at the fastest pace since early 2023 in September led by higher energy prices and a significant increase in prices of intermediate goods, pr... Read More
India, Oct. 20 -- Teva Pharmaceutical Industries Ltd. (TEVA) and Sanofi (SNY) announced positive long-term Phase 2b data for investigational duvakitug, showing sustained improvements in ulcerative col... Read More
India, Oct. 19 -- Bausch Health Canada Inc., a subsidiary of Bausch Health Companies Inc. (BHC), announced expanded public reimbursement for PrOKEDI (risperidone extended-release injectable suspension... Read More
India, Oct. 19 -- Shares of Summit Therapeutics Inc. (SMMT) are rising 7 percent in Monday morning trading after the company announced the initiation and opening of clinical trial sites of a multiregi... Read More
India, Oct. 19 -- Disc Medicine, Inc. (IRON) announced a proposed underwritten public offering of $350 million of its common stock and, for certain investors, pre-funded warrants to purchase common st... Read More
India, Oct. 19 -- BioCardia, Inc. (BCDA), a biotechnology company developing cellular and cell-derived therapies for cardiovascular and pulmonary diseases, announced that the U.S. Food and Drug Admini... Read More
India, Oct. 19 -- Veradermics, Incorporated (MANE) is up 6.98 percent, gaining $7.60 to $116.42 on Monday. The rise follows positive topline results from Part A of the company's Phase 3 Study '304' ev... Read More